Aimmune: Current Lows Look Attractive, But Coronavirus May Play Spoilsport [Seeking Alpha]
DBV Technologies S.A. - American Depositary Shares (DBVT)
US:NASDAQ Investor Relations:
dbv-technologies.com/en/investor-relations
Company Research
Source: Seeking Alpha
SummaryAIMT is currently near its 52-week lows after Palforzia's approval.The bullish view differs with the bearish one on the commercial potential issue.Here I weigh both views and figure out - for myself - if this looks investible.Aimmune Therapeutics (What is important now is to understand whether the current terrible crash in the stock - one that has brought it back down to below what it was when I recommended buying it - is an opportunity or a disaster.On the opportunity front, there are mainly four arguments. One, that this crash has been across the board due to the coronavirus, therefore there is nothing wrong with the AIMT story, therefore it will rise again. Two, Palforzia's potential will be realized once it begins to be commercialized. Three, Palforzia is simply the tip of the proverbial iceberg and AIMT has a rich pipeline of allergy medications and other assets. Lastly, Palforzia is right now the only game in town after DBV Technologies' (DBVTOn the disaster front, what i
Show less
Read more
Impact Snapshot
Event Time:
DBVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DBVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DBVT alerts
High impacting DBV Technologies S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
DBVT
News
- DBV Technologies (NASDAQ:DBVT) was upgraded by analysts at Guggenheim to a "strong-buy" rating. They now have a $35.00 price target on the stock.MarketBeat
- DBV Technologies (NASDAQ:DBVT) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.MarketBeat
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025GlobeNewswire
- DBV Technologies (NASDAQ:DBVT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- DBV Technologies (NASDAQ:DBVT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
DBVT
Sec Filings
- 11/25/25 - Form 4
- 11/24/25 - Form 4
- 11/24/25 - Form 4
- DBVT's page on the SEC website